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Henrique Seiji Ivamoto, Hernani Pinto Lemos Jr., Alvaro Nagib Atallah-BACKGROUND: Chronic subdural hematomas (CSDHs) are common neuro-
surgical conditions among elderly patients.
-OBJECTIVE: To perform a detailed critical appraisal of all randomized
controlled trials (RCTs) of surgical treatments for chronic subdural hematomas
and to quantify their intervention effects.
-METHODS: We performed a broad search for all RCTs with no language or
date restrictions, asked the authors for missing data, and applied the Cochrane
methods.
-RESULTS: A total of 24 RCTs involved 1900 patients and 15 comparisons. All
outcomes of practical interest were analyzed. Postoperative drainage after burr-
hole evacuation reduced the rate of recurrence (risk ratio 0.48, 95% confidence
interval 0.34L0.66, P < 0.00001) with no other clear benefits or complications.
-CONCLUSIONS: This comprehensive, best evidenceLbased, quantitative,
systematic review indicates that the use of a closed system drainage after burr-
hole evacuation reduces the rate of recurrences but has no other significant
differences. The findings also suggest that: (1) treatment with twist drills is
equivalent to that with burr holes; (2) the postoperative bed header in the
elevated position might reduce the length of hospital stay; (3) irrigation of the
subdural space with thrombin solution in patients with high risk of recurrence
might reduce this risk; and (4) treatment with twist drill followed by a closed
system drainage during 48 hours, instead of 96 hours, might reduce general
complication rates. Most of the trials suffered from unclear or high risks of bias
and many involved small samples, precluding strong and definitive conclusions.
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Chronic subdural hematomas (CSDHs) are
among the most common neurosurgical
conditions, and they affect mainly the aged
patient,1-11 with an incidence reaching 58.1
per 100,000 in the population that is 65 years
old or older.12 As the world population
becomes progressively older,13 the overall
incidence is expected to increase. CSDHs
occur bilaterally in approximately 19% of
the cases and affect the male sex more
often.2,3,7,8,12,14-26
The cleavage plane where subdural he-
matomas lie is the loose dural border cell
layer located in the inner portion of the dura
mater.27 CSDHs result from bleeding from
parasagittal bridging veins, caused by
trauma of slight or moderate intensity.28
The subdural hematoma becomes covered
by a thin membrane in its inner aspect and
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).WORLD NEUROSURGERY 86: 399-418, Fa thick outer membrane that contains
macrocapillaries (sinusoidal vessels) with
increased permeability and endothelial
gap junctions that permit the leakage
of blood and enlargement of the
hematoma.29,30
Subdural hematomas are classified into
acute (within 3 days of trauma), subacute
(420 days), and chronic (after 20 days), and
cases with no history of trauma are classified
according to the total duration of symp-
toms.19 The diagnosis of CSDH is difficult
to make on the basis of clinical findings
alone31 and requires the use of examinations
such as computed tomography or magnetic
resonance imaging. The overall surgical
mortality has ranged from 0% to
32%8,14,19,20,22,23,32 and the recurrence rate
from 0.36% to 33.3%.23,33EBRUARY 2016 wwSome authors have found that removal
of the membranes is unnecessary to cure
the disease,25,34 whereas others have
observed that the adequate drainage of
hematoma decreases the vascularity and
cellularity of the membranes, which
eventually disappear.35-38
As a general rule, asymptomatic CSDHs
are considered nonsurgical. In the same
way, asymptomatic recollections of he-
matoma, detected by imaging methods
and showing no signs of cerebral
compression, are not subjected to new
surgical drainage. The decision to operate
or to reoperate is based on the presence of
symptoms and clinical or imaging signs of
cerebral compression.39-44 The definition
of recurrence used by most authors and
adopted in this review is that of aw.WORLDNEUROSURGERY.org 399
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hematoma that requires reoperation of any
kind, including redrainage by percuta-
neous needle aspiration.
There are various techniques to open
the skull to remove subdural hematomas.
Twist-needle craniostomies are usually
less than 2 mm in diameter.45 Weigel
et al.46 classified openings of the skull
up to a diameter of 5 mm as twist-drill
craniostomy, openings of up to 30 mm
as burr-hole craniostomy or enlarged burr-
hole craniostomy, and larger openings as
craniotomy. The sizes of the instruments
available to create twist-drill and burr-hole
craniostomies cross the 5-mm boundary.
In an analysis of the results of 5 retro-
spective studies comparing the recurrence
rates after 1 versus 2 burr-hole cranios-
tomies, investigators found no significant
differences.47
Many studies have reported on different
types of interventions during the surgical
treatment of CSDHs, but questions remain
regarding their effectiveness and safety. The
many doubts concerning the surgical treat-
ment of CSDHs require a systematic review
analyzing the evidences available.48-50
The objective of the present systematic
review was to collect and analyze all of the
randomized controlled trials (RCTs)
available, to evaluate their risks of bias
critically, and to quantify the effects of the
various procedures for the surgical treat-
ments of CSDHs by applying the Cochrane
Collaboration methods and its statistical
software.51 This review addresses whether
one type of treatment is more effective or
safer than other types.MATERIALS AND METHODS
We used the methods described in the
Cochrane Handbook for Systematic Reviews of
Interventions.51Types of Studies
We aimed at identifying and analyzing
all of the RCTs currently available,
comparing one type of intervention for
the surgical treatment of CSDHS with
another type of intervention or with
nonsurgical treatment. One study based
on minimization52 was included because
this method is considered equivalent to
randomization.51,53400 www.SCIENCEDIRECT.comTypes of Participants
Patients were included of any sex or age
with CSDHs. Patients with CSDHs sec-
ondary to cranial procedures and those
presenting with cerebrospinal fluid shunt,
calcified hematomas, and other subdural
collections, such as hygromas, effusions,
and empyemas, were excluded.
Outcomes
All outcomes of practical value described
in the included studies were analyzed,
preferably at their final follow-ups.
Search Methods
Our search was not limited by language or
date of publication. We searched the
following electronic databases: MEDLINE
(PubMed), Cochrane Central Register of
Controlled Trials (CENTRAL), EMBASE,
LILACS, IBECS (Spain), and the meta-
Register of Controlled Trials. We also
searched the reference lists of studies and
books. The corresponding authors of the
included studies were contacted for un-
published or unclear data. The study
selection and data extraction were per-
formed by 2 authors independently, and
there were no disagreements. Analyses of
the study data were performed by all of
the authors independently, followed by
discussions.
Assessment of Risk of Bias
Biases are systematic errors or deviations
from the truth that can cause underesti-
mation or overestimation of the interven-
tion effects. The assessment of the risks of
bias provides an estimate of the extent to
which the results of a trial can be trusted.
We applied the Cochrane Collaboration
domain-based risk of bias tool, which
classifies the risks as low, high, or unclear.
Measurements of Treatment Effect
Statistical analyses for the measurement
of the treatment effects were performed
with the Cochrane Review Manager
software (RevMan), version 5.2 (The
Nordic Cochrane Centre, Copenhagen,
Denmark). For dichotomous outcomes,
we used risk ratios (RR) with 95% confi-
dence intervals (CIs), measurements that
are preferable to odds ratios.51 For
continuous outcomes, mean differences
between the effects of the interventions
were used with 95% CIs. P values also
were recorded. Meta-analyses wereWORLD NEUROSURGERY, http://performed for 2 or more comparable
studies of interventions delivered in
similar manners. Statistical heterogeneity
among studies was evaluated by the over-
lapping of CIs in forest plots, by the c2 test,
and by the inconsistency index. Fixed-effect
estimates of the Mantel-Haenszel method
were used. When heterogeneity was sub-
stantial, with an inconsistency index
greater than 50%, the random-effects
model was applied. When the losses to
follow-up made an intention-to-treat anal-
ysis impossible, we performed available
cases analyses.RESULTS
The total number of citations found in our
searches of databases, reference lists, and
books was 1739, and 1715 of them were
excluded. The 24 remaining studies met our
inclusion criteria, with data available for
1900 patients, mostly adults (Table 1). We
found no RCT dedicated specifically to
children. Corresponding authors supplied
unpublished data regarding 9 RCTs. The
studies were performed in various regions
of the world. Nineteen studies were
analyzed as intention to treat. Analyses
were limited to available cases in 6 studies
because of attrition. Sensitivity analyses
were performed when necessary.
Risk of Bias in Included Studies
The assessments of the risk of bias in the
included studies are summarized in
Table 2.
Random Sequence Generation (Selection
Bias). There was low risk of bias in 11
studies, unclear risk in 9 studies, and high
risk in 4 studies. These 4 studies61,64,66,76
used alternation as the method for random
sequence generation (Tables 1 and 2).
Allocation Concealment (Selection Bias). Only
6 studies presented adequate allocation
concealment,55,69-72,75 whereas 12 presented
unclear risk of bias and 6 presented high risk
of bias. Among these 6 high-risk studies, 4
used alternation,61,64,66,76 and 2 had the
random allocation sequence open to the
staff 59,74 (Tables 1 and 2).
Blinding of Personnel and Participants (Per-
formance Bias). Twenty two trials pre-
sented a high risk of performance bias
(Table 2) because blinding of personnel
and participants (patients) are verydx.doi.org/10.1016/j.wneu.2015.10.025
Table 1. Included Studies
First Author
and Year Country
Age Range in Years
(Mean or Means)*
Number of
Randomized
Patients, N
Method of Random
Sequence Generation
(Selection Bias)
Method of Allocation
Concealment
(Selection Bias) ITT or ACA
Abouzari 200754 Iran 21e88 (mean 56.5) 84 Unstated Unstated ITT
Ahmed 201155,y India 17e85 (mean 53) 51 Computer software Sequence concealed ITT
Erol 200556 Turkey 20 or older, except for one 70 Unstated Unstated ITT
Gai 200257 China 8e83 (mean 62.5) 120 Unstated Unstated ITT
Gjerris 197458 Denmark 33e80 9 Random numbers tables Unstated ITT
Gokmen 200859,y Turkey 35e98 (mean 67) 70 Random numbers table Allocation sequence
open to the staff
ITT
Gurelik 200760 Turkey Age range unstated (means 58.4 and 59.2) 80 Unstated Unstated ITT
Hirashima 200261 Japan 47e79 (means 65.7 and 66.7) 48 Alternation ACA
Ishfaq 200962 Pakistan 30e97 (mean 60) 60 Random numbers table Unstated ITT
Javadi 201163,y Iran 18e96 (mean 67) 40 Unstated Unclear bias riskz ITT
Kaliaperumal 201264,y Ireland 17e91 52 Alternation ACA
Laumer 198965 Germany Adults 144 Unstated Unstated ITT
Muzii 200566 Italy 63e94 (means 78.7 and 76.3) 61 Alternation ACA
Nakaguchi 200067 Japan 41e92 (mean 68.1) 63 Unstated Unstated ITT
Nakajima 200268 Japan 47e93 (mean 72.8) 46 Unstated Unstated ITT
Poulsen 201469,y Denmark Minimum 18 (mean 67.5) 50 Computer software Sealed envelopes ACA
Ram 199352,y Israel Adults (means 71.5 and 70.4) 37 Minimization with no random component ITT
Santarius 200970 UK 36e95 (mean 76.8) 215 Web-based block randomization Sealed envelopes ITT and ACA
Shimamura 200971,y Japan Minimum 18 (means 70.5 and 74.1) 79 Coin toss ITT
Sindou 2010 and
Ibrahim 201072,y
France 36e92 (mean 75) 65 Papers mentioning either 48 h or 96 h, similar in shape,
extracted by resident a few hours before surgery
ITT
Singh 201173 India No infants (means 59.8 and 61.2) 100 Computer software Unreported ACA
Singh 201474,y India 9e95 (one patient younger than
18 in each group)
200 Computer software Allocation sequence open
to the staff
ITT
Tsutsumi 199775 Japan 19e92 (mean 67) 118 Coin toss ITT
Wakai 199076 Japan 42e84 (means 70.8 and 71.7) 38 Alternation ITT
Total 1900 19 ITT and
6 ACA
Sindou 201072 and Ibrahim 201077 refer to the same study.
ITT, intention-to-treat analyses; ACA, available cases analyses.
*Age range: mean age of all patients or age means of each randomized group.
yAuthors supplied unpublished data to clear doubts about their studies.
zIn the study by Javadi et al., allocation sequence was only available to the first author, and after installing the burr-hole and irrigation, the staff was informed regarding whether to insert the
drainage system or to terminate surgery.
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most types of interventions used in
surgical treatments. Only 2 studies
presented a low risk of bias, one that
tested the postoperative use of a drug69WORLD NEUROSURGERY 86: 399-418, Fand the other the use of thrombin
irrigation during surgery71; both
interventions were compared with
placebos with adequate blinding of the
personnel and participants.EBRUARY 2016 wwBlinding of Outcome Assessors (Detection
Bias). Low risk of detection bias was
found in 4 studies,63,69,71,72 in which
outcome assessments were performed by
blinded physicians. High risk of bias wasw.WORLDNEUROSURGERY.org 401
Table 2. Risk of Bias Summary for Each Study
Seven Domains
at Right, according
to the Cochrane
Collaboration
methods51 (24
Studies Evaluated)
Random
Sequence
Generation
(Selection Bias)
Allocation
Concealment
(Selection bias)
Blinding of
Participants and
Personnel (Patients
and Staff)
(Performance Bias)
Blinding of
Outcome
Assessment
(Detection Bias)
Incomplete
Outcome Data
(Attrition Bias).
Details in Table 3
Selective
Reporting
(Reporting Bias)
Unevenness
of Preoperative
mRS (Other Bias).
Details in Table 4
Abouzari 200754 ? ? H ? L ?
Ahmed 201155 L L H H L L
Erol 200556 ? ? H ? L ?
Gai 200257 ? ? H ? L ?
Gjerris 197458 L ? H H L ?
Gokmen 200859 L H H H L ?
Gurelik 200760 ? ? H ? L ?
Hirashima 200261 H H H H H ?
Ishfaq 200962 L ? H ? L ?
Javadi 201163 ? ? H L L ?
Kaliaperumal 201264 H H H H H L ?
Laumer 198965 ? ? H H L ?
Muzii 200566 H H H ? H ?
Nakaguchi 200067 ? ? H H L ?
Nakajima 200268 ? ? H ? L ?
Poulsen 201469 L L L L H L
Ram 199352 ? ? H H L ?
Santarius 200970 L L H ? L/H L ?
Shimamura 200971 L L L L L ?
Sindou 2010 and
Ibrahim 201072
L L H L L ?
Singh 201173 L ? H ? H ?
Singh 201474 L H H H L ?
Tsutsumi 199775 L L H ? L ?
Wakai 199076 H H H ? L ?
Total 11 L
9 ?
4 H
6 L
12 ?
6 H
2 L
0 ?
22 H
4 L
11 ?
9 H
19 L
0 ?
6 H
4 L
20 ?
0 H
0 L
2?
0 H
?, unclear risk of bias; H, high risk of bias; L, low risk of bias.
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assessments were performed by unblinded
assessors. Unclear risk was found in 11
studies, in which blinding of outcome
assessments was unreported or the clini-
cians were masked to outcome assess-
ments only when possible (Table 2).
Incomplete Outcome Data (Attrition
Bias). Attrition was present in 5
studies,61,64,66,69,73 and in another study70402 www.SCIENCEDIRECT.comfor outcomes other than recurrence only
(Tables 2 and 3). The remaining 19 studies
did not present losses to follow-up.
Selective Reporting (Reporting Bias). The
research protocols of 4 studies55,64,69,70 were
obtained, and the differences found were
not causes of selective reporting, indicating
a low risk of bias. In the remaining 20
studies, although no selective reporting was
identified comparing the results with theWORLD NEUROSURGERY, http://methods sections of the articles, the
research protocols were not obtained and
were classified as presenting an unclear risk
of bias (Table 2).
Unevenness of Preoperative Modified Rankin
Scale (mRS) Scores (Other Bias). The mRS is
a reliable instrument to measure global
disability, originally applied for evaluating
stroke patient outcomes and as end point
in RCTs.78 The unevenness of preoperativedx.doi.org/10.1016/j.wneu.2015.10.025
Table 3. Details of the Risks of Attrition Bias: Incomplete Outcome Data
Low risk Abouzari 2007,54 Ahmed 2011,55 Erol 2005,56 Gai
2002,57 Gjerris 1974,58 Gokmen 2008,59 Gurelik
2007,60 Ishifaq 2009,62 Javadi 2011,63 Laumer
1989,65 Nakaguchi 2000,67 Nakajima 2002,68 Ram
1993,52 Santarius 200970 (for recurrences),
Shimamura 2009,71 Sindou 2010 & Ibrahim 2010,72
Singh 2014,74 Tsutsumi 1997,75 Wakai 1990.76
No attrition reported except for Nakajima 2002,68 in which one case was missing from
one group (supine), for an observed event rate of 4/34 for this group (supine) and 3/21
for the other group (sitting). A sensitivity analysis, considering the missing case as
having recurrence or no recurrence, showed that the direction of the results and the
conclusion of statistical nonsignificance did not change.
Santarius et al.70 stated on page 1070 of the trial report that their primary outcome
(recurrence) was measured for all patients.
High risk Hirashima 200261 Nine of the 24 patients assigned to the etizolam group were dropped from the study
because the duration of drug administration was less than 3 days. In the reevaluation,
performed between 2 and 3 months postoperatively, 3 more patients from the etizolam
group were lost to follow-up, and no data were available concerning their outcomes.
There were no losses in the control group.
Kaliaperumal 201264 Two patients, one from each group, were excluded from the trial because of premature
dislodgment of the drain before 48 hours. The event rates for dichotomic outcomes were
0/25 and 1/25.
Muzii 200566 Fifteen patients were lost to or had incomplete follow-up and were excluded from the
study, and the data available are on the remaining 46. The event rates ranged between
0/22 and 5/24.
Poulsen 201469 Among the 50 randomized patients, 3 were excluded because they withdrew their
consents after randomization, one from the perindopril arm and 2 from the placebo arm;
no other information was available about them. The event numbers for dichotomic
outcomes were 0 and 2.
Santarius 200970 (for outcomes other than
recurrence)
Losses were reported for their secondary outcomes. The losses for the evaluation of
Glasgow Coma Scale at discharge were 14/108 (13%) in the drain group and 10/107
(9.4%) in the no-drain group. At 6 months, a follow-up questionnaire was mailed to
patients for them to complete, with assistance from family members or caregivers if
necessary, asking about their accommodation, independence, mobility status, and
modified Rankin Scale scores. The incomplete responses to these postal questionnaires
for secondary outcomes were high: (a) 31/108 (28.7%) in the drain group; (b) 20/107
(18.7%) in the no-drain group; and (c) 51/215 (23.7%) among all of the randomized
patients. The observed event risk for these clinical outcomes ranged between 5/67
(7.5%) and 64/76 (84%) in the drain group and between 9/67 (13%) and 60/85 (71%) in
the no-drain group. Because of the losses, analyses of the secondary outcomes were
performed based on the available cases. An unusual feature of this study, compared
with the other reviewed trials, was that it did not report a final (6 months) follow-up
clinical examination in all patients, for their primary and secondary outcomes.
Singh 201173 Three patients from the same group were lost to follow-up. The event rates for
recurrences and mortality ranged between 0 and 4.
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Table 4.
Effects of Interventions
The comparisons and outcomes presented
in this review are those contained in the
primary studies. The 24 RCTs included 15
comparisons of practical interest. We
performed the statistical analyses using
the Cochrane Collaboration software on
the raw numerical data extracted from the
studies. Only the main comparisons and
effects are presented here. Details on the
effects of all of the interventions, with
their values and comments, are shown in
Table 5.WORLD NEUROSURGERY 86: 399-418, FComparison 1. Treatment of CSDH with
burr hole and irrigation of the subdural
space associated with (A) a postoperative
closed drainage system to a soft bag versus
(B) no postoperative drainage. This com-
parison was performed in 8 studies
involving 828 patients: Ahmed et al.,55 Erol
et al.,56 Javadi et al.,63 Laumer et al.,65
Santarius et al.,70 Singh et al.,74 Tsutsumi
et al.,75 and Wakai et al.76 A meta-analysis
combining the data from the 8 studies
and all 828 patients showed statistically
significant results favoring the use of post-
operative drainage concerning recurrence
rates (RR 0.48, 95% CI 0.340.66, P <
0.00001) (Figure 1). A meta-analysis limitedEBRUARY 2016 wwto the results of 3 studies with adequate
allocation concealment55,70,75 involving
384 participants also showed statistically
significant results favoring the use of
postoperative drainage (RR 0.38, 95% CI
0.220.65, P ¼ 0.0004) (Figure 2). No
statistically significant differences between
the 2 interventions were found in the
meta-analyses regarding mortality at final
follow-up among 609 patients,55,56,63,70,74,76
(Figure 3), complications other than
recurrence and death among 672
patients,55,56,63,65,70,74 (Figure 4), good
recovery at final follow-up among 175
patients55,56,63,76 (Figure 5), infections
among 366 patients56,65,74 (Figure 6),w.WORLDNEUROSURGERY.org 403
Table 4. Details on Risks of Other Bias: Unevenness of the Preoperative modified Rankin Scale (mRS) Scores
Unclear risks Santarius 200970 This trial reported on 6 outcome analyses with adjusted logistic regression models by independent variables and their P values on
its page 1072. The P values of the effects of the use of postoperative drain compared with the P values of the effects of the
admission mRS78 scores on these 6 outcomes, were: (1) for recurrence rate, 0.0210 versus 0.4770; (2) for mortality at 30 days,
0.2870 versus 0.0510; (3) for mortality at 6 months, 0.0330 versus 0.0070; (4) for unfavorable mRS (4e6) at discharge, 0.0330
versus <0.0001; (5) for unfavorable mRS (4e6) at 6 months, 0.2073 versus 0.0147; and (6) for Glasgow Coma Scale score of 15
(full consciousness) at discharge, 0.0334 versus 0.0002. These comparisons showed that the effect of the use of subdural drains,
with direct local biomechanical effects on this space, was superior to the effect of admission mRS concerning the recurrence of
subdural hematomas. However, the effect of admission mRS score, which reflects the preoperative clinical state, was greater
than the effect of the use of drains concerning the 5 clinical outcomes analyzed. For each of the 5 clinical outcomes, the effect of
admission mRS score was greater than the effect of the use of drain. These data showed a remarkable prognostic value of the
mRS score at admission, a reliable measurement of the initial clinical state.
On the other hand, according to the baseline characteristics shown on page 1068 of the trial report, among the 32 patients with
admission mRS scores of 2 (slight disability), there were more patients randomized for drain than for no drain (21 vs. 11), whereas
among the 56 patients with admission mRS score of 5 (severe disability), there were fewer patients randomized for drain than for
no drain (23 vs. 33). mRS score of 5 (severe disability) is applied to patients who are bedridden, incontinent and requiring constant
nursing care and attention. mRS score of 6 refers to death.78 Compared with the group randomized to receive no drain, the group
randomized to receive a drain had more patients with slight disability and fewer patients with severe disability. Regarding mRS
scores of 1, 3, and 4, the preoperative distributions between the two groups were almost identical. The overall admission mRS
data distribution, with all 5 scores analyzed together, was statistically homogeneous (P ¼ 0.20). Nevertheless, considering the
strong clinical prognostic effects of admission mRS score, it is likely that the unevenness of scores 2 and 5 favored the results of
the drain group for all clinical outcomes, except recurrences. In fact, considering the adjustment for confounding factors, the trial
authors stated on page 1071 that drain was not predictive of mRS score at 6 months and that admission mRS score was a
significant predictor of this score at 6 months.
Kaliaperumal
201264
The trial authors comment that preoperative mRS scores were better in the subperiosteal drain group than in the subdural drain
group, causing a potential bias in the overall outcome and subsequent results. Our analysis showed that the preoperative mean
difference in mRS scores was slightly favorable to the subperiosteal drainage group, with no statistical significance (P ¼ 0.61).
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or early Glasgow Coma Scale of 15 among
431 patients.63,70,74 The analysis of the data
from individual studies of outcomes that
were not meta-analyzed did not show any
other clear benefit or harms associated with
the use of drains. As shown in the figures
and in Table 5, the number of patients
varied according to the primary studies
involved in each outcome analysis.
Comparison 2. Treatment of CSDHwith (A) 1
or 2 twist-drill craniostomies (with orwithout
irrigation, and postoperative drainage to a
suction reservoir or to a soft bag) versus (B) 1
or 2 burr-hole craniostomies, irrigation,
and postoperative drainage to a soft bag.
This comparison was performed by 4
studies: Gokmen et al.,59 Gurelik et al.,60
Muzii et al.,66 and Singh et al.73 No
statistically significant differences between
the treatments with twist-drill and burr-
hole craniostomies were found in the
meta-analyses of the data from these 4
studies regarding recurrence rates among
293 patients (Figure 8), mortality among
213 patients,59,66,73 (Figure 9), other
complications among 165 patients,59,73404 www.SCIENCEDIRECT.com(Figure 10), or cure rates among 216
patients59,66,73 (Figures 11 and 12).
Comparison 3. Treatment of CSDH in adults
with 1 or 2 burr-hole craniostomies and
postoperative bed header in (A) flat position
versus (B) elevated position. This comparison
was considered by 3 studies involving 189
patients: Abouzari et al.,54 Ishfaq et al.,62 and
Nakajima et al.68 No statistically significant
differences between the 2 postoperative
positions were found in the meta-analysis
regarding recurrences among 189 pa-
tients54,62,68 (Figure 13) and overall
complications among 144 patients54,62
(Figure 14). The data from Ishfaq et al.62
from 60 patients showed that an elevated
bed header position was associated with
reduced length of hospital stay in days
(mean difference 0.77, 95% CI 0.301.23,
P ¼ 0.001). No statistically significant
differences were found regarding other
outcomes.
Comparison 4. TreatmentofunilateralCSDH
in adults by 1 burr-hole craniostomy with
irrigation and closed-system drainage for 48
hours with the subdural drainage catheter tipWORLD NEUROSURGERY, http://positioned in the frontal region versus (A) the
occipital region, (B) the parietal region, or (C)
the temporal base region. A trial was per-
formed by Nakaguchi et al.67 in 63 patients.
No statistically significant differences were
found between these procedures regarding
recurrence rates, although there was a
tendency to favor the frontal position.
Comparison 5. Treatment of CSDH with
single burr-hole craniostomy and irrigation
followed by postoperative subdural or sub-
periosteal drainage and daily treatment over
3 months with (A) perindopril versus (B)
placebo. A trial was performed by Poulsen
et al.69 in 47 patients. There were no
recurrences, surgical complications, or
deaths. There were no statistically
significant differences regarding medical
complications or the volume of remnant
CSDH 6 weeks postoperatively.
Comparison 6. Treatment of adults with
high risk of recurrence of CSDHwith 1 burr-
hole craniostomy, closed drainage over 24
hours, and intravenous tranexamic acid over
24 hours, associated with intraoperative
irrigation with (A) thrombin solution (100dx.doi.org/10.1016/j.wneu.2015.10.025
Table 5. Effects of Interventions with Comments (15 Comparisons from 24 Studies)
First Author and Year Outcomes
Risk Ratio RR or
Mean Difference (95% CI) P Values I2*
Comparison 1: Treatment of CSDH with burr-hole and irrigation of the subdural space associated with (A) postoperative closed drainage system to a soft bag versus (B)
no postoperative drainage
Ahmed 2011,55 Erol 2005,56 Javadi 2011,63 Laumer 1989,65
Santarius 2009,70 Singh 2014,74 Tsutsumi 1997,75 Wakai
1990.76 All studies that made the comparison. (N ¼ 828)
Recurrences (n ¼ 828), Figure 1 RR 0.48 (0.340.66) < 0.00001 36%
Ahmed 2011,55 Santarius 2009,70 Tsutsumi 1997.75 Only studies
with adequate allocation concealment. (N ¼ 384)
Recurrences (n ¼ 384), Figure 2 RR 0.38 (0.220.65) 0.0004 1%
Ahmed 2011,55 Erol 2005,56 Javadi 2011,63 Santarius 2009,70
Singh 2014,74 Wakai 199076 (N ¼ 609)
Mortality at final follow-up (n ¼ 609),
Figure 3
RR 0.82 (0.491.37) 0.46 11%
Ahmed 2011,55 Erol 2005,56 Javadi 2011,63 Laumer 1989,65
Santarius 2009,70 Singh, 201474 (N ¼ 672)
Complications other than recurrence and
death (n ¼ 672), Figure 4
RR 0.96 (0.731.27) 0.77 32%
Ahmed 2011,55 Erol 2005,56 Javadi 2011,63 Wakai 199076
(N ¼ 175)
Good recovery at final follow-up (n ¼ 175),
Figure 5
RR 1.08 (0.901.28) 0.41 14%
Results of Santarius et al.70 not included because the use of drain was not predictive of mRS score at 6
months, whereas admission mRS score was a significant predictor of it (p. 1071 of the trial report).
Erol 2005,56 Laumer 1989,65 Singh 201474 (N ¼ 366) Infections (n ¼ 366), Figure 6 RR 0.82 (0.471.45) 0.50 0%
Laumer 1989,65 Singh 201474 (N ¼ 296) Seizures (n ¼ 296), Figure 7 RR 0.77 (0.302.01) 0.60 0%
Santarius 2009,70 Javadi 2011,63 Singh 201474 (N ¼ 455) Early GCS score of 15 (n ¼ 431), random
effects model
RR 1.10 (0.881.36) 0.40 54%
Santarius et al.70 found statistically significant benefit of early GCS score of 15 associated with the use
of drains, but this outcome was subject to an unclear risk of bias, as seen in Table 4.
Santarius 200970 (N ¼ 215) Mortality at 30 days (n ¼ 211) RR 0.50 (0.151.59) 0.24
Gross focal neurologic deficits at 6 months
(n ¼ 132)
RR 0.91 (0.431.96) 0.82
High level of care at 6 months (n ¼ 134) RR 0.56 (0.20 1.57) 0.27
Worse mobility at 6 months (n ¼ 102) RR 0.57 (0.26 1.24) 0.16
Singh 201474 (N ¼ 200) Intracerebral hematoma (n ¼ 200) RR 1.33 (0.315.81) 0.70
Subdural empyema (n ¼ 200) RR 0.50 (0.09 2.67) 0.42
Pneumocephalus with mass effect (n¼ 200) RR 1.25 (0.354.52) 0.73
Residual hemiparesis (n ¼ 200) RR 0.58 (0.241.42) 0.24
Pulmonary embolism (n ¼ 200) RR 1.00 (0.0615.77) 1.00
Comment: In conclusion, postoperative closed drainage to a soft bag resulted in a statistically significant reduction of the recurrence rate with no other clear benefit or
harm.
Comparison 2: Treatment of CSDH with (A) 1 or 2 twist-drill craniostomies (with or without irrigation, and postoperative drainage to suction reservoir or to a soft bag)
versus (B) 1 or 2 burr-holes craniostomies, irrigation and postoperative drainage to a soft bag
Gokmen 2008,59 Gurelik 2007,60 Muzii 2005,66 Singh 201173
(N ¼ 311)
Recurrences (n ¼ 293), Figure 8 RR 0.66 (0.311.40) 0.28 27%
Gokmen 2008,59 Muzii 2005,66 Singh 201173 (N ¼ 231) Mortality (n ¼ 213), Figure 9 RR 2.02 (0.686.04) 0.21 13%
Gokmen 2008,59 Singh 201173 (N ¼ 170) Complications other than recurrence and
death (n ¼ 165), Figure 10
RR 1.50 (0.623.61) 0.37 45%
Gokmen 2008,59 Muzii 2005,66 Singh 201173 (N ¼ 231) Cure (n ¼ 216), fixed-effects model,
Figure 11
RR 0.96 (0.861.08) 0.55 60%
Gokmen 2008,59 Muzii 2005,66 Singh 201173 (N ¼ 231) Cure (n ¼ 216) random-effects model,
Figure 12
RR 0.98 (0.801.21) 0.88 60%
Continues
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First Author and Year Outcomes
Risk Ratio RR or
Mean Difference (95% CI) P Values I2*
Comment: Because of the substantial heterogeneity concerning cure rates, revealed by an I2 greater than 50%, a random-effects Mantel-Haenszel model also was
applied, resulting in wider confidence interval and a greater P value. No statistically significant differences found in the meta-analyses. These 4 trials presented
differences among themselves regarding the surgical maneuvers associated with twist-drill craniostomies: irrigation or no irrigation, and passive or active drainage.
Nevertheless, the individual analyses of the data of each of these trials resulted in no statistically significant differences between twist-drill craniostomies and burr-hole
craniostomies regarding the aforementioned outcomes. Some authors advocated the use of twist-drill craniostomies because they are faster and can be performed at
bedside under local anesthesia. Larger studies with lower risks of bias are necessary.
Comparison 3: Treatment of CSDH in adults with 1 or 2 burr-hole craniostomies and postoperative bed header in (A) flat position versus (B) elevated position
Abouzari 200754, Ishifaq 200962, Nakajima 200268 (N ¼ 189) Recurrences (n¼ 18 9), Figure 13 RR 1.07 (0.422.69) 0.89 0%
Abouzari 200754, Ishifaq 200962 (N ¼ 144) Overall complications (n ¼ 144), Figure 14 RR 1.22 (0.73 2.04) 0.44 0%
Ishifaq 200962 (N ¼ 60) Hospital stay (n ¼ 60) Mean difference 0.77 (0.301.23) 0.001
Wound infection (n ¼ 60) RR 2.00 (0.1920.90) 0.56
Seizures (n ¼ 60) RR 0.67 (0.12 3.71) 0.64
Abouzari 200754 (N ¼ 84) Atelectasis (n ¼ 84) RR 1.43 (0.603.40) 0.42
Pneumonia (n ¼ 84) RR 1.25 (0.364.33) 0.73
Decubitus ulcer (n ¼ 84) RR 1.50 (0.268.52) 0.65
Deep-vein thrombosis (n ¼ 84) RR 0.33 (0.01 7.96) 0.50
Comment: No statistically significant differences found, except for reduction in the length of hospital stay found among 60 patients in one study.
Comparison 4: Treatment of unilateral CSDH in adults by 1 burr-hole craniostomy with irrigation and closed-system drainage for 48 hours with the subdural drainage
catheter tip positioned in the frontal region versus (A) the occipital region, (B) the parietal region, or (C) the temporal base region
Nakaguchi 200067 (N ¼ 63) A) Frontal versus occipital (n ¼ 46):
recurrences
RR 0.24 (0.031.88) 0.17
B) Frontal versus parietal (n ¼ 29):
recurrences
RR 0.13 (0.021.05) 0.06
C) Frontal versus temporal base (n ¼ 30):
recurrences
RR 0.14 (0.021.20) 0.07
Comment: It is believed that placing the catheter tip in the frontal region facilitates air removal, reducing the risks of recurrence. Statistical significance was not reached
possibly due to the small sample sizes. Larger studies are necessary to evaluate this simple and possibly effective surgical measure better.
Comparison 5: Treatment of CSDH with single burr-hole craniostomy and irrigation followed by postoperative subdural or subperiosteal drainage and daily treatment over
3 months with (A) perindopril versus (B) placebo
Poulsen 201469 (N ¼ 50) No recurrences, surgical complications or deaths (n ¼ 47)
Medical complications (dry coughs) (n¼ 47) RR 4.42 (0.22 87.44) 0.33
Preoperative CSDH volumes (mL) (n ¼ 47) Mean difference: 6.46 (43.24, 30.32) 0.73
Volume of remnant CSDH 6 weeks
postoperatively (mL) (n ¼ 47)
Mean difference: 5.61 (22.63, 11.41) 0.52
Comment: No statistically significant differences were found. It is believed that angiotensin-converting enzyme inhibitors, such as perindopril, can reduce the
development of new and immature blood vessels in the hematoma neomembrane, which could diminish the extravasation of fluid into the CSDH and reduce the risk of
recurrence. Patients who were incapable of understanding and agreeing to participate were excluded from the study. Among the 50 randomized patients, 3 were
excluded because they withdrew their consents, one from the perindopril and 2 from the placebo arm, and no further information about these patients was available.
Comparison 6: Treatment of CSDH in adults with high risk of recurrence with 1 burr-hole craniostomy, closed drainage during 24 hours and intravenous tranexamic acid
over 24 hours, associated with intraoperative irrigation with (A) thrombin solution (100 units/mL) versus (B) saline solution
Shimamura 200971 (N ¼ 79) Recurrences (n ¼ 79) RR 0.22 (0.050.92) 0.04
Continues
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Mean Difference (95% CI) P Values I2*
Comment: Tranexamic acid is an antifibrinolytic drug. The trial authors postulated that thrombin irrigation of the subdural space could induce a hemostatic reaction in the
sinusoidal vessels situated in the CSDH capsule and avoid recurrences. The study involved adult patients with high risk of recurrence, including those with old age, use
of antiplatelets, anticoagulants, hematologic disease, chronic renal failure, liver cirrhosis, and recurrence from previous drainage. The analysis showed that the
intraoperative irrigation with thrombin solution was associated with a statistically significant lower recurrence rate. Further studies are recommendable. It would be
interesting to examine the effectiveness of thrombin solution irrigation in CSDH patients commonly seen in practice, with the usual risks of recurrence.
Comparison 7: Treatment of CSDH in adults with twist-drill craniostomy and no irrigation, followed by closed system drainage over (A) 48 hours versus (B) 96 hours
Sindou 2010 and Ibrahim 201072 (N ¼ 65) General complication rate (n ¼ 65) RR 0.12 (0.020.94) 0.04
Neurologic complications (n ¼ 65) RR 0.86 (0.135.72) 0.87
Recurrences (n ¼ 65) RR 1.14 (0.28 4.71) 0.85
Reoperation because clinical status did not
improve and residual hematoma was of a
significant volume (n ¼ 65)
RR 1.71 (0.1617.98) 0.65
Overall deaths (n ¼ 65) RR 0.21 (0.031.81) 0.16
Deaths from neurologic causes (n ¼ 65) RR 0.86 (0.0613.12) 0.91
Deaths of general causes (n ¼ 65) RR 0.12 (0.012.29) 0.16
Comment: The analyses showed a statistically significant lower rate of general complications with the 48 hours of drainage. No other statistically significant differences
were found.
Comparison 8: Treatment of CSDH with burr-hole craniostomy, irrigation, drainage for 1 to 4 days and postoperative (A) Trendelenburg position, hyperhydration, and
hypoxic training versus (B) supine position, oxygen and fluid restriction
Gai 200257 (N ¼ 120) Postoperative subdural fluid accumulation
(n ¼ 120)
RR 0.44 (0.141.37) 0.16
Comment: No statistically significant differences were found. The trial authors gave as an example of “hypoxic training” the blow up of a balloon.
Comparison 9: Treatment of CSDH in adults with (A) craniotomy versus (B) mannitol infusion
Gjerris 197458 (N ¼ 9) Failure rates (n ¼ 9) RR 0.18 (0.01 2.25) 0.18
Comment: The failures occurred in the seven patients randomized to the mannitol arm. These patients had to switch to craniotomy and the authors considered it
unjustifiable to continue the trial.
Comparison 10: Treatment of unilateral CSDH in adults with burr-hole craniostomy and irrigation, followed postoperatively by (A) etizolam versus (B) no etizolam
Hirashima 200261 (N ¼ 48) Drop outs (n ¼ 48) (all drop outs occurred
in the etizolam group)
RR 19.00 (1.17309.11) 0.04
Recurrences (n ¼ 36) (available cases
analysis)
RR 0.17 (0.01 2.92) 0.22
Volume of residual hematoma or dilated
subdural space one month after surgery
(n ¼ 39) (available cases analysis)
Mean difference: 16.30 mL (22.32,
10.28)
<0.00001
Comment: According to the trial authors, etizolam is an antagonist of platelet-activating factor that could prevent CSDH recurrence. Nine patients were dropped from the
study because the duration of etizolam administration was less than 3 days. The large losses in this arm of the study caused a very high risk of attrition bias.
Comparison 11: Treatment of CSDH in adults with 2 burr-hole craniostomies and irrigation, followed over 48 hours postoperatively by (A) subperiosteal drainage to a
minivac suction device versus (B) subdural drainage to a soft collection bag.
Kaliaperumal 201264 (N ¼ 52) No recurrences (n ¼ 50)
Deaths (n ¼ 50) RR 0.33 (0.01 7.81) 0.49
Complications other than death (n ¼ 50) RR 1.00 (0.07, 15.12) >0.99
Preoperative MRS (n ¼ 50) Mean difference: 0.20 (0.97, 0.57) 0.61
mRS scores 3 months after surgery (n ¼
50)
Mean difference: 0.52 (1.01, 0.03) 0.04
MRS 6 months postoperatively (n¼50) Mean difference: 0.68 (1.20, 0.16) 0.01
Continues
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Comment: In the subperiosteal technique, the standard silicone ventriculostomy tube was placed in such a manner as to cover both burr holes. Although this trial
suggested that subperiosteal drainage to a minivac suction device could result in better clinical results than the commonly used subdural drainage to a soft collection
bag, further studies are necessary. Two patients, one from each arm, were excluded from the study because of premature removal of drains before the end of the 48-
hour period.
Comparison 12: Treatment of CSDH in adults with 1 burr-hole irrigation and (A) permanent subdural drain and subcutaneous Rickham reservoir for percutaneous drainage
versus (B) temporary subdural closed drainage system
Laumer 198965 (N ¼ 97) Recurrences (n ¼ 97) RR 0.94 (0.481.85) 0.86
Infections (n ¼ 97) RR 0.51 (0.055.45) 0.58
Postoperative seizures (n ¼ 97) RR 2.04 (0.1921.78) 0.55
Comment: No statistically significant differences were found.
Comparison 13: Treatment of CSDH in adults with 1 burr-hole irrigation and (A) permanent subdural drain and subcutaneous Rickham reservoir for percutaneous drainage
versus (C) no postoperative drainage system
Laumer 198965 (N ¼ 95) Recurrences (n ¼ 95) RR 0.98 (0.491.96) 0.95
Infections (n ¼ 95) RR 0.98 (0.06 15.20) 0.99
Postoperative seizures (n ¼ 95) RR 0.98 (0.146.67) 0.98
Comment: No statistically significant differences were found. According to the report, new guidelines were established in their department following the trial: the
permanent subdural drain connected to a Rickham reservoir for percutaneous drainage was indicated primarily in patients in whom the brain did not expand sufficiently
during surgery and secondarily in those patients in whom reoperation became necessary. No other trials of this technique were found.
Comparison 14: Treatment of CSDH in adults with 2 burr-hole craniostomies and postoperative 48e96 hours of drainage to a bag, associated with (A) continuous
irrigation of the subdural space versus (B) no irrigation
Ram 199352 (N ¼ 37) Recurrences (n ¼ 37) RR 0.24 (0.031.92) 0.18
Complications (n ¼ 37) RR 0.47 (0.102.28) 0.35
Comment: No statistically significant differences were found. The objective of the continuous irrigation of the subdural space was to remove the fibrinolytic agents to
avoid recurrences. Intracranial pressure was monitored via a strain gauge transducer connected to the irrigation drainage catheter to detect any possible malfunction of
the draining catheters. One patient suffered transient deterioration of consciousness with hemiparesis as the result of blocked drains with a patent irrigation tube, but
this complication was detected early and was reversed by replacement of the blocked drains. Continuous irrigation of the subdural space requires careful monitoring of
the intracranial pressure in an intensive care unit.
Comparison 15: Treatment of CSDH in adults with high risk of recurrence on antiplatelets, with 1 burr-hole craniostomy, closed drainage during 24 hours, and intravenous
tranexamic acid over 24 hours, associated with intraoperative irrigation with (A) thrombin solution (100 units/mL) versus (B) saline solution
Shimamura 200971 (N ¼ 79) Recurrences (n ¼ 34) (available cases
analysis)
RR 0.11 (0.011.91) 0.13
Comment: This comparison, limited to 34 patients on antiplatelets, was done in a subgroup of the originally randomized study with 79 patients with high risk of
recurrences of various causes. No statistically significant differences were found.
RR, risk ratio; CI, confidence interval; I2, inconsistency index; N, number of randomized patients; n, number of patients available for the outcome analysis; CSDH, chronic subdural hematoma;
mRS, modified Rankin Scale; GCS, Glasgow Coma Scale.
The overlapping of CIs, which occur at variable degrees, can be seen in the figures showing the forest plots on the meta-analyses. A lack of overlap of CIs means strong statistical
heterogeneity.
*A rough guide to interpretation of the heterogeneity according to the I
2
is as follows: 0%40%, might not be important; 30%60%, may represent moderate heterogeneity; 50%90%, may
represent substantial heterogeneity; 75%100%, considerable heterogeneity.51
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was performed by Shimamura et al.71 in 79
patients. Irrigation with thrombin solution
resulted in a statistically significant
reduction in the rate of recurrences (RR
0.22, 95% CI 0.050.92, P ¼ 0.04).408 www.SCIENCEDIRECT.comComparison 7. Treatment of CSDH in adults
with twist-drill craniostomy and no irriga-
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associated with statistically significant
lower rates of general complication
(RR 0.12, 95% CI 0.020.94, P ¼ 0.04).
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Figure 1. Forest plot showing the effects of treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the
subdural space associated with (A) a postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome:
Recurrences requiring reoperation (all studies). CI, confidence interval.
Figure 2. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Recurrences requiring reoperation
(only studies with adequate allocation concealment).
Figure 3. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Mortality rates at final follow-up.
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Figure 4. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Complications other than recurrence
and death.
Figure 5. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Good recovery at final follow-up.
Figure 6. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Infections.
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Figure 7. Treatment of chronic subdural hematomas with burr-hole craniostomy and irrigation of the subdural space associated with (A) a
postoperative closed drainage system to a soft bag versus (B) no postoperative drainage. Outcome: Seizures.
Figure 8. Treatment of chronic subdural hematomas with (A) 1 or 2 twist-drill craniostomies (TDC), with or without irrigation, and
postoperative drainage to a suction reservoir or to a soft bag, versus (B) 1 or 2 burr-hole craniostomies (BHC), irrigation, and postoperative
drainage to a soft bag. Outcome: Recurrences requiring reoperation.
Figure 9. Treatment of chronic subdural hematomas with (A) 1 or 2 twist-drill craniostomies (TDC), with or without irrigation, and
postoperative drainage to a suction reservoir or to a soft bag, versus (B) 1 or 2 burr-hole craniostomies (BHC), irrigation, and postoperative
drainage to a soft bag. Outcome: Mortality rates.
Figure 10. Treatment of chronic subdural hematomas with (A) 1 or 2 twist-drill craniostomies (TDC), with or without irrigation, and
postoperative drainage to a suction reservoir or to a soft bag, versus (B) 1 or 2 burr-hole craniostomies (BHC), irrigation, and postoperative
drainage to a soft bag. Outcome: Complications other than recurrences and deaths.
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Figure 11. Treatment of chronic subdural hematomas with (A) 1 or 2 twist-drill craniostomies (TDC; with or without irrigation, and
postoperative drainage to a suction reservoir or to a soft bag) versus (B) 1 or 2 burr-hole craniostomies (BHC), irrigation, and postoperative
drainage to a soft bag. Outcome: Cure (fixed effects model).
Figure 13. Treatment of chronic subdural hematomas in adults with burr-hole craniostomies and postoperative bed header in (A) flat
position versus (B) elevated position. Outcome: Recurrences requiring reoperation.
Figure 14. Treatment of chronic subdural hematomas in adults with burr-hole craniostomies and postoperative bed header in (A) flat
position versus (B) elevated position. Outcome: Overall complications.
Figure 12. Treatment of chronic subdural hematomas with (A) 1 or 2 twist-drill craniostomies (TDC; with or without irrigation, and
postoperative drainage to a suction reservoir or to a soft bag) versus (B) 1 or 2 burr-hole craniostomies (BHC), irrigation, and postoperative
drainage to a soft bag. Outcome: Cure (random effects model).
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Table 6. Summary of Main Findings and Quality of Evidence
Comparison 1: Treatment of CSDH with burr hole and irrigation of the subdural space associated with (A) postoperative closed drainage system to a soft bag versus (B)
no postoperative drainage
Outcome Drain No Drain Relative Effect (95% CI) Number of
patients
Quality of
evidence
(GRADE)
Comments
Recurrence 16/198 (8.1%) 41/186 (22.0%) RR 0.38 (0.22e0.65) 384 (only the 3
studies with
adequate
allocation
concealment)
Moderate
to high
I2 ¼ 1%,
NNT ¼ 8
Mortality at final follow-up 24/305 (7.9%) 29/304 (9.5%) RR 0.82 (0.491.37) 609 (6 studies) Moderate I2 ¼ 11%
Complications other than
recurrences and deaths
68/337 (20.2%) 71/335 (21.2%) RR 0.96 (0.731.27) 672 (6 studies) Moderate I2 ¼ 32%
Good recovery at final
follow-up
68/89 (76.4%) 61/86 (70.9%) RR 1.08 (0.901.28) 175 (4 studies) Moderate I2 ¼ 14%
Infections 19/184 (10.3%) 23/182 (12.6%) RR 0.82 (0.471.45) 366 (3 studies) Moderate I2 ¼ 0%
Seizures 7/149 (4.7%) 9/147 (6.1%) RR 0.77 (0.30 2.01) 296 (2 studies) Moderate I2 ¼ 0%
Early postoperative GCS
score of 15
148/214 (69%) 137/217 (63%) RR 1.10 (0.88 1.36) 431 (3 studies) Moderate I2 ¼ 54%,
Comparison 2: Treatment of CSDH with (A) 1 or 2 twist-drill craniostomies (with or without irrigation, and postoperative drainage to a suction reservoir or to a soft bag)
versus (B) 1 or 2 burr-hole craniostomies, irrigation and postoperative drainage to a soft bag
Outcome Twist Drill Burr Hole Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
Evidence
(GRADE)
Comments
Recurrences 10/146 (6.8%) 16/147 (10.9%) RR 0.66 (0.31 1.40) 293 (3 studies) Low I2 ¼ 27%
Mortality 9/108 (8.3%) 4/105 (3.8%) RR 2.02 (0.686.04) 213 (3 studies) Low I2 ¼ 13%
Complications other than
recurrences and deaths
11/85 (12.9%) 7/80 (8.7%) RR 1.50 (0.023.61) 165 (2 studies) Low I2 ¼ 45%
Cure 88/108 (81.5%) 92/108 (85.2%) RR 0.98 (0.801.21) 216 (3 studies) Low I2 ¼ 60%
Comparison 3: Treatment of CSDH in adults with 1 or 2 burr-hole craniostomies and postoperative bed header in (A) flat position versus (B) elevated position
Outcome Flat Position Elevated Position Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
Evidence
(GRADE)
Comments
Recurrences 8/96 (8.3%) 7/93 (7.5%) RR 1.07 (0.422.69) 189 (3 studies) Low I2 ¼ 0%
Overall complications 22/72 (30.6%) 18/72 (25%) RR 1.22 (0.73 2.04) 144 (2 studies) Low I2 ¼ 0%
Comparison 4: Treatment of unilateral CSDH in adults by 1 burr-hole craniostomy with irrigation and closed-system drainage for 48 hours with the subdural drainage
catheter tip positioned in the frontal region versus the occipital region.
Outcome Frontal Region Occipital Region Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
Evidence
(GRADE)
Comments
Recurrence 1/21 (5%) 5/25 (20%) RR 0.24 (0.03, 1.88) 46 (1 study) Low
Comparison 5: Treatment of CSDH with single burr-hole craniostomy and irrigation followed by postoperative subdural or subperiosteal drainage and daily treatment
during 3 months with (A) perindopril versus (B) placebo
Outcome Perindopril
(ACE inhibitor)
Placebo Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
the Evidence
(GRADE)
Comments
Volume of remnant CSDH 6
weeks postoperatively (mL)
22.77 (SD 31.3)
n ¼ 25
28.3 (SD 28.24)
n ¼ 22
Mean difference 5.61 (22.63, 11.41) 47 (1 study) Moderate No recurrences;
the trial excluded
patients with
impaired
consciousness.
Continues
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Table 6. Continued
Comparison 6: Treatment of adults with high-risk of recurrence CSDH with 1 burr-hole craniostomy, closed drainage during 24 hours, and intravenous tranexamic acid
during 24 hours, associated with intraoperative irrigation with (A) thrombin solution (100 unit/mL) versus (B) saline solution
Outcome Thrombin
Solution
Saline Solution Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
Evidence
(GRADE)
Comments
Recurrences 2/36 (5.6%) 11/43 (25.6%) RR 0.22 (0.050.92) 79 (1 study) Moderate NNT¼ 5
Comparison 7: Treatment of CSDH in adults with twist-drill craniostomy and no irrigation, followed by closed system drainage during (A) 48 hours versus (B) 96 hours
Outcome 48 Hours 96 Hours Relative Effect (95% CI) Number of
Patients
(Studies)
Quality of
Evidence
(GRADE)
Comments
General complications 1/35 (2.9%) 7/30 (23.3%) RR 0.12 (0.020.94) 65 (1 study) Moderate NNT¼ 5
CSDH, chronic subdural hematoma; RR, risk ratio; CI, confidence interval; GRADE, Grading of Recommendations Assessment, Development and Evaluation; I2, inconsistency index; NNT, number
needed to treat; GCS, Glasgow Coma Scale; ACE, angiotensin-converting enzyme.
GRADE Working Group grades of evidence. High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have
an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in
the estimate of effect and is likely to change the estimate. Very low quality: An estimate of effect is very uncertain.
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shown in Table 5.DISCUSSION
We will discuss only the main findings. For
a summary, including the quality of the
evidence (Grading of Recommendations
Assessment, Development and Evaluation
Working Group), see Table 6. The use of
postoperative drains after burr-hole evacu-
ation of CSDH reduced the rate of re-
currences by a statistically significant level,
with no other clear benefits or harms. The
postoperative drainage time lasted approx-
imately 2 days. The use of drains is a
common procedure used in various surgi-
cal fields to eliminate blood or secretions,
and it would be expected to reduce the rate
of recurrences of CSDHs through its local
biomechanical effects. Although the rate of
recurrence was reduced, no significant
clinical benefits were found associated with
this reduction. Clinical benefits from burr-
hole craniostomies seemed to be more
dependent on the patient’s preoperative
clinical state than on the use of drains, as
indicated by the data of a regression lo-
gistic analysis,70 discussed in Table 4.
Regarding common concerns with the use
of drains because of the potential risks of
infections, cortical injuries, and seizures,
no statistically significant side effects were
identified.
The treatment of CSDH with twist drills
compared with burr-hole craniostomies
showedno significant differences regarding414 www.SCIENCEDIRECT.comrecurrence, mortality, other complications,
or cure rates based on studies with mostly
unclear or high risks of bias. Several authors
have advocated the use of twist-drill cra-
niostomies because they are faster and can
be performed at bedside under local anes-
thesia. Larger studies with a lower risk of
bias are needed.
The treatment of adults with 1 or 2 burr-
hole craniostomies and postoperative bed
headers in flat versus elevated positions,
according to the data from primary studies
with mostly unclear risks of bias, showed
no statistically significant differences
regarding recurrences or other complica-
tions. One study62 showed a significant
reduction in the length of hospital stay
associated with elevated positioning.
The treatment of CSDH by one burr-
hole craniostomy with irrigation and
closed system drainage with the subdural
catheter tip positioned in the frontal re-
gion instead of other regions resulted
in reductions in the recurrence rates that
did not reach statistical significance in a
small study67 with mostly unclear risks
of bias. Larger studies could better
evaluate this simple and possibly helpful
procedure.
After evacuation of CSDH, the post-
operative administration of perindopril,
compared with placebo, did not result in a
significant reduction in the volume of the
remnantCSDH.69No recurrence occurred in
either group. It is believed that angiotensin-
converting enzyme inhibitors, such as peri-
ndopril, can reduce the development of newWORLD NEUROSURGERY, http://and immature blood vessels in the hema-
toma neomembrane, which would diminish
the extravasation of fluid into the CSDH and
reduce the risk of recurrence.
The treatment of adults with high risk of
recurrence of CSDH with burr-hole cra-
niostomy, closed drainage, and intravenous
tranexamic acid associated with intra-
operative irrigation with thrombin solution
instead of irrigation with saline solution
resulted in a statistically significant reduc-
tion in the rate of recurrence in a study71
with low risks of bias in 79 patients.
Tranexamic acid is an antifibrinolytic
drug. The study involved older patients,
use of antiplatelets or anticoagulants,
hematologic disease, chronic renal failure,
liver cirrhosis, and recurrence from
previous drainage. Further studies are
recommendable, and it would be
interesting to evaluate the effectiveness of
thrombin solution irrigation in patients
with CSDH commonly seen in practice
andpresenting theusual risks of recurrence.
The treatment of CSDH with twist-drill
craniostomy and no irrigation, followed
by closed system drainage over 48 hours,
instead of 96 hours, resulted in statistically
significant lower general (non-neurolog-
ical) complication rates in a study72,77 with
a mostly low risk of bias in 65 patients. No
statistically significant differences were
found regarding other outcomes.
The other 8 comparisons are commented
on, along with the effects of their in-
terventions, in Table 5. Most of the
comparisons analyzed in this reviewdx.doi.org/10.1016/j.wneu.2015.10.025
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differences, and many studies were small or
were associated with unclear or high risks
of bias.
Main Aspects of This Review
Our broad search for RCTs of surgical
treatments for CSDHs was unrestricted by
language or publication date. The quanti-
tative analyses, performed with the
Cochrane statistical software, were inde-
pendent of the analyses presented by the
original trial reports.
Different from the other reviews of
CSDHs, this review included unpublished
data supplied by trial authors to eliminate
doubts, quantitative analyses of all out-
comes of practical interest found in each
study, and a detailed critical analysis of the
risks of bias, according to the Cochrane
methods. Isolated studies were analyzed
because this review was not restricted to
meta-analyses, the statistical combination
of results from two or more separate
studies.
Instead of publishing various shorter re-
views, all 15 comparisons contained in the 24
RCTs were presented in this single,
comprehensive, critical, quantitative sys-
tematic review. This approach was used for
the benefit of readers involved in busy
neurosurgical practices or residence training.
Previous Reviews
Some reviews were not focused on RCTs.
They analyzed Class II and Class III evi-
dence46; used Monte Carlo simulation and
sensitivity analyses,49 combined
prospective and retrospective studies79;
reviewed retrospective studies80; or
commented on various management
issues in a narrative review.81
Four systematic reviews published in
2014 focused on RCTs, but they were
mostly82 or entirely83-85 restricted to meta-
analyses, and various outcomes of
practical interest reported in the primary
studies were not analyzed.
One of these reviews85 covered medical
and surgical therapies for CSDH based
on 234 observational studies and 16
RCTs, applied language restrictions and
classified all RCTs as presenting a low
risk of performance bias despite the
impossibility of blinding personnel and
patients to most surgical procedures. Its
meta-analyses of mortality considered
one RCT data59 before hospital dischargeWORLD NEUROSURGERY 86: 399-418, Finstead of overall deaths, and their data
from another trial73 differed from the
trial report. Its meta-analyses lacked 2
older RCTs55,76 and a new one.74
Two meta-analyses of another review82
include 3 studies86-88 that we did not
classify as RCTs: one study86 reported
that the surgical procedure was up to the
preference of the attending neurosurgeon
on call; another87 stated that their study
was retrospective; and the other88
reported that the operative techniques
were randomized to the attending
neurosurgeon, and because there were
only 2 teams, they were randomized to
either team A or team B, which were on
call that day. This review82 evaluated all
of their included studies as presenting
low risks for performance, detection, and
reporting bias, unlike the usual views.51
Its meta-analyses lacked one older RCT62
and a new RCT.74
Two other reviews83,84 evaluated studies
with the commonly used Jadad scale,
which emphasizes reporting rather than
conduct and does not consider allocation
concealment,51 which is an essential
aspect in the assessment of RCTs. The
meta-analyses83 of postoperative bed
header position in CSDH included a
study89 that contains subacute
hematomas.
One of these reviews84 found a
statistically significant reduction in the
risk of poor functional outcome with the
use of postoperative subdural drains.
This undue positive finding was caused
by the inclusion in their meta-analysis of
the data of a study on the mRS score at
6 months, which suffered from
confounding factors, as described in our
Table 4 (“Details on other bias”).
Aside from the differences mentioned
above, our results were similar to those
obtained by these reviewers.82-85
Limitations of This Review
As shown in Table 2, regarding the risks of
bias for each primary study, indicating an
estimate of the extent to which the results
can be trusted, most trials suffered from
unclear or high risks, which weakened
the strength of the evidences. Only 6
primary studies reported adequate
allocation concealment with low risks of
selection bias, whereas the concealment
was unclear in 12 and inadequate in 6.
Most of the outcome comparisons wereEBRUARY 2016 wwrestricted to small numbers of patients,
and no multicentric studies were found.
These limitations precluded strong and
definitive conclusions.
This unfavorable scenario is common
in all clinical areas, particularly in sur-
gery, in which RCTs with a low risk of
bias are more difficult to achieve. In
contrast, it is encouraging that the still
small number of RCTs is increasing
steadily and more than half of the studies
found for the present review were pub-
lished in the last 10 years.CONCLUSIONS
This comprehensive and best evidence-
based quantitative systematic review
indicated that the use of closed-system
drainage after burr-hole evacuation
reduced the rate of recurrences and was
associated with no other significant
benefit or harm, according to the data
currently available. It also suggested that:
(1) treatment with twist drills is equivalent
to burr holes; (2) after burr-hole cranios-
tomy, the postoperative bed header in the
elevated position, instead of the supine
position, might reduce the length of hos-
pital stay; (3) irrigation of the subdural
space with thrombin solution associated
with postoperative tranexamic acid in pa-
tients with high risk of recurrence might
reduce this risk; and (4) treatment with a
twist drill, followed by closed-system
drainage during 48 hours instead of 96
hours, might reduce general complication
rates. Most trials available suffered from
unclear or high risks of bias and involved
small numbers of patients, precluding
strong and definitive conclusions.
Implications for Clinical Research
CSDHs are common neurosurgical condi-
tions and a rich field for basic and clinical
investigations. We hope that this review,
being critical and comprehensive and
providing various comparisons that require
further study of surgical treatments, might
be useful to potential authors interested
in preparing a RCT. It should help to
avoid the commonly observed risks of
bias, such as the use of alternation to
allocate patients. Well-designed and -per-
formed RCTs with low risks of bias are
necessary for precise assessments of the
effectiveness and safety of treatments. In a
pragmatic trial addressing the effectivenessw.WORLDNEUROSURGERY.org 415
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treat strategy should be adopted, main-
taining the participants in the groups to
which they were randomized regardless of
withdrawals, noncompliance, or protocol
deviations, thereby preserving the prog-
nostic balance from the original random
allocation, minimizing false-positive re-
sults, and favoring generalization. The
protocol should include measures to avoid
losses and, if possible, to follow up the
patients who leave the study to obtain
complete outcome data for every random-
ized participant. Attrition causes difficulties
in the analyses of results, particularly when
the event risks are low. Multicentric studies
should be encouraged.51,53,90-96ACKNOWLEDGMENTS
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